Replimune Group, Inc.

REPLNasdaqCIK 1737953HealthcareFiscal year ends Mar 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 169 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Replimune Group, Inc., Reports and events
Filed	Form	What it is	Accession number
2021-08-0608:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001104659-21-101099
2021-07-2216:00 ET	DEF 14A	Proxy statementPeriod 2021-09-08	0001104659-21-094885
2021-06-0308:03 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-21-076114
2021-05-2008:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001104659-21-069613
2021-05-2008:05 ET	10-K	Annual reportPeriod 2021-03-31	0001104659-21-069611
2021-05-1008:45 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0001104659-21-063503
2021-05-0508:33 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-21-061404
2021-04-2108:54 ET	8-K	5.02 Departure or appointment of officers or directors	0001104659-21-052874
2021-04-1216:46 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-21-049367
2021-02-0408:26 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001104659-21-011954
2021-02-0408:17 ET	10-Q	Quarterly reportPeriod 2020-12-31	0001104659-21-011950
2021-01-1107:48 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-21-002712
2020-12-2109:20 ET	8-K	1.02 Termination of a material agreement	0001104659-20-137760
2020-11-0508:19 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001104659-20-121601
2020-11-0508:18 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001104659-20-121600
2020-10-2316:39 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-117740
2020-10-2221:32 ET	8-K	8.01 Other events	0001104659-20-116888
2020-10-2016:37 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-116455
2020-10-1917:13 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-20-116131
2020-10-1417:14 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-114973
2020-09-1716:50 ET	SC 13D/A	Ownership report, active investor, amended	0001387131-20-008366
2020-09-1016:01 ET	8-K	5.07 Shareholder vote results	0001104659-20-103933
2020-08-2516:45 ET	8-K/A	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits	0001104659-20-098397
2020-08-1117:16 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits	0001104659-20-093357
2020-08-0716:24 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001104659-20-091998
2020-08-0708:04 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001104659-20-091744
2020-07-2909:02 ET	DEF 14A	Proxy statementPeriod 2020-09-09	0001047469-20-004296
2020-07-2208:12 ET	8-K	5.02 Departure or appointment of officers or directors	0001104659-20-085399
2020-07-0717:11 ET	SC 13D/A	Ownership report, active investor, amended	0001387131-20-006203
2020-07-0106:03 ET	8-K	8.01 Other events	0001104659-20-079316
2020-06-1917:03 ET	SC 13D/A	Ownership report, active investor, amended	0001387131-20-005813
2020-06-1016:27 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-072032
2020-06-0816:04 ET	8-K	8.01 Other events	0001104659-20-070829
2020-06-0307:28 ET	10-K	Annual reportPeriod 2020-03-31	0001047469-20-003318
2020-06-0307:26 ET	8-K	1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001104659-20-069223
2020-06-0307:25 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-20-069222
2020-04-0616:23 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-20-043704
2020-02-1311:31 ET	10-Q	Quarterly reportPeriod 2019-12-31	0001104659-20-019880
2020-01-1516:01 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-20-004310
2020-01-1008:45 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001104659-20-002849
2019-12-2317:03 ET	8-K	5.02 Departure or appointment of officers or directors	0001104659-19-075653
2019-12-0917:02 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001104659-19-071037
2019-11-2517:17 ET	SC 13D	Ownership report, active investor	0001104659-19-067100
2019-11-1808:02 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-19-064897
2019-11-1209:23 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001104659-19-062211
2019-11-1209:21 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001104659-19-062207
2019-11-0816:30 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001104659-19-061729
2019-10-1508:24 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-19-053935
2019-09-1016:00 ET	8-K	5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001104659-19-049527
2019-08-1416:35 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001104659-19-045944

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 3, 2026, 23:32 ET. Listed shows no prices and gives no investment advice.